XML 54 R37.htm IDEA: XBRL DOCUMENT

Insider Trading Arrangements

3 Months Ended

12 Months Ended

Dec. 31, 2024

During the three months ended December 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described below:

Name and Title

Character of Trading Arrangement (1)

Date Adopted

Duration (2)

Aggregate Number of Shares of Common Stock to be Sold Pursuant to Trading Arrangement

Anita Mahon, Executive Vice President and Business Head, Healthcare

Rule 10b5-1
Trading Arrangement

November 04, 2024

July 31, 2025

37,817

Ajay Ayyappan,

Executive Vice President, General Counsel & Corporate Secretary

Rule 10b5-1
Trading Arrangement

November 12, 2024

May 30, 2025

32,156

(1) Except as indicated by footnote, each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended (the “Rule”).

(2) Except as indicated by footnote, each trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales or (b) the date listed in the table. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule.

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Anita Mahon [Member]

Trading Arrangements, by Individual

Name

Anita Mahon

Title

Executive Vice President and Business Head, Healthcare